Johanna Gebhart's presentation at #WFHCCS walked through a clear, step-by-step approach to diagnosing mild to moderate #BleedingDisorders—including how to handle complex cases and rare conditions. A valuable learning moment! 🩸
Postpartum hemorrhage is a significant risk for many women yet the etiology is not well understood. New study from @demoreuil and team shows that women with PPH have a different fibrin network than those who did not.
https://t.co/FCyzFZHmNT
@b_petesch@b_petesch@FCouturaud@Cihan_Ay_MD
We are thrilled to share our new publication in @BloodAdvances on altered plasmin generation and plasma clot structure in patients with #BDUC. This was a great collaboration study with @aswolberg and her team! @JoGebhart@IngridPabinger@Cihan_Ay_MD
https://t.co/COAXFznz04
Scientist by day, Musician by night.
Highly recommended listening to this #podcast hosted by @GBarnesMD with @DanielSteinerMD on his research in #VTE & experiences. Great example of the valuable contribution of young researcher to #thrombosis. #WTDay24
https://t.co/H96aPxypTK
Congratulations to @dino_mehic, a member of the Vienna Thrombosis and Haemostasis Research Group, for being selected as Researcher of the Month at our university @MedUni_Wien.
https://t.co/NSgklXqtLP
It was a fantastic and well-organized #ISTH2024 meeting in Bangkok. Thanks to @isth for the opportunities it gives to early career researchers to share their novel data. 🙏🌟
Big thanks to all speakers, chairs, abstract presenters & participants of #GTH2024 for your invaluable contributions to this wonderful congress with days of full education, science, exchange, inspiration and fun in #thrombosis and #hemostasis in the beautiful @hofburg. @JoGebhart
1 Month to go.
So excited to host the GTH 2024 Congress in Vienna, Austria. It is the 68th Annual Meeting of the German, Austrian and Swiss Society of Thrombosis and Haemostasis Research (GTH).
Check out the great program ➡️ https://t.co/PvfZOzXicK… https://t.co/4VtJ7rP6cX
In our recent study from the VIBB, our data emphasize an overlap between #VWD and #BDUC patients. Repeated testing of #VWF values might be necessary for patients with mild to moderate bleeding tendency, especially if VWF <80 IU/dL. @JoGebhart@Cihan_Ay_MD@JTHjournal@MedUni_Wien
▶️ Patients with with bleeding disorder of unknown cause have a reduced health-related quality of life 🙎♂️🪫
▶️ Early recognition and better counseling of patients with BDUC is needed 💬 👥
▶️ new study from the Vienna bleeding biobank 🩸🏥: https://t.co/uikoxAgHIQ @RPTHjournal